INNV vs VMD
INNV: InnovAge operates integrated primary care and chronic disease management centers under the PACE model for frail elderly populations, earning capitated fees from government payors. VMD: Viemed provides home-based respiratory, chronic care, and women's health services with clinical practitioners delivering therapy and equipment rental to patients across all 50 US states.
Side-by-side fundamentals
| Metric | INNV | VMD | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $11.48 | $12.12 | |
| Market cap as of 2026-07-30 | $1.6B | $465M | |
| P/E as of 2026-07-30 | n/a | 30.08 | |
| PEG as of 2026-07-30 | n/a | 0.93 | |
| Net margin as of 2026-07-30 | -1.2% | +5.2% | VMD higher |
| Gross margin as of 2026-07-30 | +21.8% | +57.6% | VMD higher |
| Operating margin as of 2026-07-30 | -1.0% | +8.2% | VMD higher |
| ROE as of 2026-07-30 | -4.8% | +10.7% | VMD higher |
| ROA as of 2026-07-30 | -2.2% | +7.6% | VMD higher |
| Debt / equity as of 2026-07-30 | 0.30 | 0.06 | VMD lower |
| Revenue growth (YoY) as of 2026-07-30 | +14.1% | +23.1% | VMD higher |
| Revenue CAGR (3y) SEC XBRL | +6.9% | +24.9% | VMD higher |
| Beta as of 2026-07-30 | 0.38 | 1.12 | |
| 1-year return as of 2026-07-27 close | +199.0% | +98.0% | INNV higher |
Fundamentals: market data, as of 2026-07-30. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.